[EN] DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES<br/>[FR] DÉRIVÉS DE DIAZÈNIUMDIOLATE CYCLOHEXYLE
申请人:MERCK SHARP & DOHME
公开号:WO2012151114A1
公开(公告)日:2012-11-08
The present invention includes diazeniumdiolate cyclohexyl derivatives, such as a compound having the structure of formula (I) wherein R1-R13 are as defined herein, including various pharmaceutically acceptable salts and hydrates thereof, and pharmaceutical formulations comprising the diazeniumdiolate cyclohexyl derivatives. The invention also includes a method for treating hypertension, Pulmonary Arterial Hypertension (PAH), congestive heart failure, conditions resulting from excessive water retention, cardiovascular disease, diabetes, oxidative stress, endothelial dysfunction, cirrhosis, pre-eclampsia, osteoporosis or nephropathy, comprising administering a compounds of the invention to a patient having such a condition, or being at risk to having such condition.
本发明包括二氮酸二酯环己基衍生物,例如具有以下结构的化合物(I)其中R1-R13如本文所定义,包括各种药用盐及其水合物,以及含有二氮酸二酯环己基衍生物的药物配方。该发明还包括一种治疗高血压、肺动脉高压(PAH)、充血性心力衰竭、由过多水分潴留引起的疾病、心血管疾病、糖尿病、氧化应激、内皮功能障碍、肝硬化、子痫前期、骨质疏松症或肾病的方法,包括向患有该疾病或有患有该疾病风险的患者施用本发明的化合物。